Generic substitution in the treatment of epilepsy: Patient and physician perceptions
Authors:
- Robert A. GrossRGRobert A. Gross
- Lisa S. HaskinsLHLisa S. Haskins
- Wendy M. ZingaroWZWendy M. Zingaro
- Kenneth J. TomaszewskiKTKenneth J. Tomaszewski
- 1 November 2008
- journal article
- Published by Elsevier in Epilepsy & Behavior
- Vol. 13 (4) , 693-699
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Generic substitution in the treatment of epilepsyNeurology, 2008
- Pharmacy and Generic Substitution of Antiepileptic Drugs: Missing in Action?Annals of Pharmacotherapy, 2007
- Position statement on the coverage of anticonvulsant drugs for the treatment of epilepsyNeurology, 2007
- Are there potential problems with generic substitution of antiepileptic drugs?Seizure: European Journal of Epilepsy, 2006
- Patient and physician reactions to generic antiepileptic substitution in the treatment of epilepsyEpilepsy & Behavior, 2005
- Potential Savings from Substituting Generic Drugs for Brand-Name Drugs: Medical Expenditure Panel Survey, 1997–2000Annals of Internal Medicine, 2005
- Therapeutic equivalency of generic antiepileptic drugs: results of a surveyEpilepsy & Behavior, 2004
- A physician survey on generic drugs and substitution of critical dose medicationsArchives of internal medicine (1960), 1997
- Assessment [RETIRED]Neurology, 1990
- The debate over substitution policy: Its evolution and scientific basisThe American Journal of Medicine, 1985